Clinical Trial

A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This study is designed to evaluate the safety and tolerability of NVC-001 in adults with LMNA-related dilated cardiomyopathy (LMNA-DCM). The study will also assess exploratory measures of efficacy.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-08
critical Primary endpoint(s) modified 2026-07-08
notable Trial sites expanded: 1 -> 6 locations 2026-07-08
Trial Details
NCT Number NCT07606274
Lead Sponsor Nuevocor Pte. Ltd.
Conditions LMNA-Related Dilated Cardiomyopathy
Enrollment 21 participants
Start Date 2026-06-16
Primary Completion 2030-03 (estimated)
Study Completion 2030-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-07